Skip to content

RESOURCES

Notes, evidence and documentation.

Material for clinical, technical and procurement teams evaluating PharmAlert.

Downloads

EXECUTIVE SUMMARY
What PharmAlert checks and where it fits — for clinical and executive readers.
SECURITY PACK
Data handling, hosting, access control and compliance posture, in full.
INTEGRATION GUIDE
API surface, payload shapes, standards support and implementation steps.

Request any of these through the contact form — they are sent by a person, not a download gate.

The rule set behind this site

The demonstration on this site runs against 36 curated rules across six categories of clinical risk. 14 are derived directly from the checking logic in the PharmAlert application; 22 were written for this demonstration where the application’s rule set does not yet cover the scenario. The full product rule set is considerably larger.

Try a check

POLYPHARMACY & RENAL FUNCTION

WarningPA-DOS-003

Metformin · eGFR 30–44

At this level of renal function the maximum metformin dose is reduced, typically to 1 g daily in divided doses.

Well documented · Established

SuggestedReduce the dose and review renal function every three to six months — confirm against local guidance.

WarningPA-DOS-012

Apixaban · eGFR 30–59

Moderate renal impairment raises apixaban exposure. The dose remains standard for most patients, but renal function needs to be tracked rather than assumed stable.

Well documented · Established

SuggestedReview renal function at least every six months, and reassess the dose if eGFR falls further.

Demonstration only, using fictional patients. Not for clinical use.

Ask for what you need.

Tell us which team is evaluating and we will send the right pack.

Request a pilot